Hims & Hers Health (HIMS)
(Delayed Data from NYSE)
$15.85 USD
-0.19 (-1.18%)
Updated Aug 8, 2024 04:00 PM ET
After-Market: $15.95 +0.10 (0.63%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth A Momentum A VGM
Income Statements
Fiscal Year end for Hims & Hers Health, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 872 | 527 | 272 | 0 | 0 |
Cost Of Goods | 157 | 118 | 67 | 0 | 0 |
Gross Profit | 715 | 409 | 204 | 0 | 0 |
Selling & Adminstrative & Depr. & Amort Expenses | 744 | 477 | 320 | 5 | 1 |
Income After Depreciation & Amortization | -29 | -69 | -115 | -5 | -1 |
Non-Operating Income | 8 | 3 | 4 | 2 | 2 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -22 | -66 | -111 | -3 | 1 |
Income Taxes | 2 | 0 | -3 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -24 | -66 | -108 | -3 | 1 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -24 | -66 | -108 | -3 | 1 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -26 | -61 | -109 | -5 | -1 |
Depreciation & Amortization (Cash Flow) | 4 | 8 | 6 | 0 | 0 |
Income After Depreciation & Amortization | -29 | -69 | -115 | -5 | -1 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 209.35 | 204.52 | 186.78 | 78.05 | NA |
Diluted EPS Before Non-Recurring Items | -0.11 | -0.32 | -0.42 | -0.23 | NA |
Diluted Net EPS (GAAP) | -0.11 | -0.32 | -0.58 | -0.89 | 0.08 |
Fiscal Year end for Hims & Hers Health, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | NA | 278.17 | 246.62 | 226.70 | 207.91 |
Cost Of Goods | NA | 49.08 | 42.56 | 39.39 | 37.75 |
Gross Profit | NA | 229.10 | 204.06 | 187.31 | 170.16 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 219.19 | 204.46 | 195.86 | 179.39 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 9.91 | -0.40 | -8.55 | -9.23 |
Non-Operating Income | NA | 2.50 | 2.60 | 1.64 | 2.07 |
Interest Expense | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | NA | 12.40 | 2.20 | -6.92 | -7.17 |
Income Taxes | NA | 1.28 | 0.95 | 0.65 | -0.01 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 11.13 | 1.24 | -7.57 | -7.16 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 11.13 | 1.25 | -7.57 | -7.16 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | NA | 229.37 | 221.85 | 210.14 | 208.42 |
Diluted EPS Before Non-Recurring Items | -99,999.00 | 0.05 | 0.01 | -0.04 | -0.03 |
Diluted Net EPS (GAAP) | -99,999.00 | 0.05 | 0.01 | -0.04 | -0.03 |